Nuevas herramientas para la revisión de la medicación: PRM en pacientes en tratamiento con inhibidores de la bomba de protones

Gutiérrez-Igual, Salvador; Lucas-Domínguez, Rut; Martí Rodrigo, Alberto; Romero Crespo, Isabel; Montesinos Mezquita, M Carmen.
Aten. prim. (Barc., Ed. impr.) ; 56(5)may. 2024. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-CR-341

Documentos relacionados

  1. Long-Term Use of Omeprazole: Effect on Haematological and Biochemical Parameters.
  2. Proton Pump Inhibitors and Kidney Disease: An Intertwined Relationship.
  3. Intrauterine exposure to omeprazole increases the risk of teeth morphological anomalies in the offspring of a murine model.
  4. Phase I study to evaluate of the gastric pH-dependent drug interaction between famitinib and the proton pump inhibitor omeprazole in healthy subjects.
  5. How to advise patients on the risk of chronic proton pump inhibitor therapy.
  6. Is there a correlation between hypomagnesemia linked to long-term proton pump inhibitor use and the active agent?
  7. Proton pump inhibitors associated with an increased risk of mortality in elderly: a systematic review and meta-analysis.
  8. [Appropriateness of Proton pump inhibitor (PPI) recommendation in discharge letters of a gastroenterological department].
  9. The incidence and prevalence of proton pump inhibitor usage among internal medicine patients after hospital admission: A retrospective cohort study.
  10. Proton pump inhibitor use: systematic review of global trends and practices.